Founder and CEO

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

Kuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law Firm

Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

Business Development Director, MRD Strategy

Tempus AI is a company focused on precision medicine and advancing the healthcare industry through AI technology. They are seeking a Business Development Director, MRD Strategy to lead and execute a scalable sales strategy for their Minimal Residual Disease product portfolio within the oncology community, driving market expansion and establishing Tempus as a leader in MRD testing.

Vice President, Medical Affairs & Payer Relations

Vice President, Business Development

Senior Director, Business Development

Senior Director Business Development Sequencing & CDx

Director, Business Development

Sign up with Google

Sign in with Google